title: Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs.
abstract: BACKGROUND
  The obligate intracellular protozoan parasite Toxoplasma gondii infects humans and other warm-blooded animals and establishes a chronic infection in the central nervous system after invasion. Studies showing a positive correlation between anti-Toxoplasma antibodies and incidences of brain cancer have led to the notion that Toxoplasma infections increase the risk of brain cancer. However, molecular events involved in Toxoplasma induced brain cancers are not well understood.
  
  
  OBJECTIVE
  Toxoplasma gains control of host cell functions including proliferation and apoptosis by channelizing parasite proteins into the cell cytoplasm and some of the proteins are targeted to the host nucleus. Recent studies have shown that Toxoplasma is capable of manipulating host micro RNAs (miRNAs), which play a central role in post-transcriptional regulation of gene expression. Therefore, we hypothesize that Toxoplasma promotes brain carcinogenesis by altering the host miRNAome using parasitic proteins and/or miRNAs.
  
  
  METHODS
  The miRNA expression profiles of brain cancer specimens obtained from patients infected with Toxoplasma could be analyzed and compared with that of normal tissues as well as brain cancer tissues from Toxoplasma uninfected individuals to identify dysregulated miRNAs in Toxoplasma-driven brain cancer cells. Identified miRNAs will be further confirmed by studying cancer related miRNA profiles of the different types of brain cells before and after Toxoplasma infection using cell lines and experimental animals. EXPECTED OUTCOME: The miRNAs specifically associated with brain cancers that are caused by Toxoplasma infection will be identified.
  
  
  CONCLUSIONS
  Toxoplasma infection may promote initiation and progression of cancer by modifying the miRNAome in brain cells. If this hypothesis is true, the outcome of this research would lead to the development of novel biomarkers and therapeutic tools against Toxoplasma driven brain cancers.
authors: Department of Biomedical Sciences, University of Illinois, College of Medicine, 1601 Parkview Ave, Rockford, IL, 61107, USA. mgnanas@uic.edu.
authors: Sivasakthivel
authors: S
authors: Thirugnanam
authors: Namita
authors: N
authors: Rout
authors: Munirathinam
authors: M
authors: Gnanasekar
references: Int J Parasitol. 2000 Nov;30(12-13):1217-58
references: 11113252
references: PLoS One. 2010 Sep 30;5(9):
references: 20927335
references: Cell Microbiol. 2006 Feb;8(2):301-15
references: 16441440
references: PLoS Pathog. 2010 May 27;6(5):e1000920
references: 20523899
references: Brain Pathol. 2008 Jan;18(1):122-9
references: 18226107
references: J Cereb Blood Flow Metab. 2012 Jul;32(7):1377-92
references: 22434068
references: J Neurooncol. 1993 Jul;17(1):47-64
references: 8120572
references: Acta Neuropathol. 2009 Jun;117(6):599-611
references: 19343354
references: PLoS Comput Biol. 2007 Jul;3(7):e131
references: 17630826
references: Immunobiology. 1999 Dec;201(2):248-54
references: 10631574
references: Infect Immun. 2006 Jul;74(7):4254-65
references: 16790800
references: Cancer Res. 2005 Jul 15;65(14):6029-33
references: 16024602
references: J Immunol. 1998 Feb 15;160(4):1824-30
references: 9469443
references: J Cell Physiol. 2007 Feb;210(2):370-7
references: 17111382
references: Mol Genet Genomics. 2001 Jul;265(5):905-12
references: 11523808
references: Biol Lett. 2012 Feb 23;8(1):101-3
references: 21795265
references: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2812-7
references: 19196975
references: J Biol Chem. 2001 Jun 29;276(26):24223-31
references: 11294868
references: Biochem Biophys Res Commun. 2005 Sep 9;334(4):1351-8
references: 16039986
references: Int J Parasitol. 2004 Mar 9;34(3):381-91
references: 15003498
references: J Cell Sci. 2003 Nov 1;116(Pt 21):4359-71
references: 12966164
references: Nat Rev Genet. 2012 Apr 18;13(5):358-69
references: 22510765
references: Front Biosci. 2000 Apr 01;5:D391-405
references: 10762601
references: Eur J Cancer. 2011 Nov;47(16):2479-90
references: 21775132
references: Yonsei Med J. 2006 Dec 31;47(6):862-9
references: 17191317
references: J Cell Sci. 2009 Oct 1;122(Pt 19):3511-21
references: 19737817
references: Int J Epidemiol. 1993 Jun;22(3):412-9
references: 8359956
references: Cancer Res. 2009 Apr 15;69(8):3249-55
references: 19351822
references: J Cell Sci. 2006 May 15;119(Pt 10):2119-26
references: 16638808
references: Oncogene. 2010 Jun 10;29(23):3411-22
references: 20305691
references: RNA. 2010 Jun;16(6):1268-74
references: 20423977
references: Infect Genet Evol. 2012 Mar;12(2):496-8
references: 22285308
references: Nature. 2008 Sep 4;455(7209):58-63
references: 18668040
references: Cell Mol Life Sci. 2008 Jun;65(12):1900-15
references: 18327664
references: Virology. 2011 Mar 15;411(2):325-43
references: 21277611
references: Cell Microbiol. 2007 Jun;9(6):1556-70
references: 17298390
references: Trends Parasitol. 2001 Oct;17(10):480-6
references: 11587962
references: J Nucl Med. 2010 May 1;51 Suppl 1:18S-32S
references: 20457793
references: J Cell Sci. 2001 Oct;114(Pt 19):3495-505
references: 11682609
references: Neurosurg Focus. 2010 Jan;28(1):E3
references: 20043718
references: PLoS One. 2010 Jan 15;5(1):e8742
references: 20090903
references: Lancet. 2004 Jun 12;363(9425):1965-76
references: 15194258
references: Clin Microbiol Rev. 1998 Apr;11(2):267-99
references: 9564564
references: Cancer Lett. 2008 Dec 18;272(2):197-205
references: 19013014